Theseus Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THRX and other ETFs, options, and stocks.

About THRX

Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. 

CEO
Timothy P. Clackson
CEOTimothy P. Clackson
Employees
Employees
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2017
Founded2017
Employees
Employees

THRX Key Statistics

Market cap
224.54M
Market cap224.54M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
25.50K
Average volume25.50K
High today
$6.06
High today$6.06
Low today
$5.55
Low today$5.55
Open price
$5.99
Open price$5.99
Volume
11.88K
Volume11.88K
52 Week high
$16.10
52 Week high$16.10
52 Week low
$4.01
52 Week low$4.01

THRX Earnings

-$5.16
-$3.44
-$1.72
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 9, Pre-Market
ActualExpected Mar 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.